MDMA-assisted therapy (PTSD)

MDMA-assisted therapy is a novel approach to treating post-traumatic stress disorder (PTSD) that involves using controlled doses of MDMA in conjunction with psychotherapy sessions, and it has shown promising results in reducing PTSD symptoms. Clinical trials have demonstrated significant reductions in PTSD severity among participants who received MDMA-assisted therapy compared to those on placebo. These improvements were observed across various levels of PTSD severity, from moderate to severe cases, and the effects persisted over time. Additionally, the therapy was associated with positive changes in self-experience, such as increased feelings of connection and reduced anxiety.

The therapy connects closely with other treatments for PTSD, including traditional psychotherapy and pharmacological interventions, but stands out due to its unique mechanism of action and the rapidity of symptom reduction observed in studies. It also intersects with research on the neurobiological underpinnings of trauma, as MDMA is thought to enhance emotional processing and facilitate therapeutic breakthroughs.

While the evidence from multiple randomized controlled trials is robust, more long-term follow-up studies are needed to fully understand the durability and safety of MDMA-assisted therapy for PTSD.

Sources

• MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. (PMID:33972795)
• MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. (PMID:37709999)
• [[MDMA-assisted therapy for PTSD].](https://pubmed.ncbi.nlm.nih.gov/38713560/) (PMID:38713560)
• Effects of MDMA-assisted therapy for PTSD on self-experience. (PMID:38198456)
• MDMA and MDMA-Assisted Therapy. (PMID:39741438)
• MDMA-assisted psychotherapy for the treatment of PTSD: A systematic review and meta-analysis of randomized controlled trials (RCTs). (PMID:39381877)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._